Dry powder inhaler administration
Semantic Scholar uses AI to extract papers important to this topic.
- BMC pulmonary medicine
Medications for respiratory disorders including asthma and chronic obstructive pulmonary disease (COPD) are typically… (More)
- Expert opinion on drug delivery
The objective of this randomised, cross-over study was to compare a new single-dose dry powder inhaler (Elpenhaler (EH… (More)
Combination therapy with a long-acting bronchodilator and an inhaled corticosteroid (ICS) is recommended in patients… (More)
Adding a long-acting beta(2)-agonist (LABA) by dry powder inhaler (DPI) to tiotropium provides significantly increased and… (More)
- Current medical research and opinion
To determine the effects of budesonide and formoterol administered via one pressurized metered-dose inhaler (budesonide… (More)
- Journal of clinical pharmacology
In 3 open-label studies, the systemic bioavailability of budesonide and formoterol administered via pressurized metered-dose… (More)
Mometasone furoate (MF) is a new inhaled glucocorticoid administered by dry powder inhaler (DPI).
- The Journal of allergy and clinical immunology
Mometasone furoate (MF) is a new potent corticosteroid for use in treating asthma.
To test the lower range… (More)
Aminoglycosides are a mainstay of therapy for patients with cystic fibrosis (CF) or non-CF bronchiectasis who are infected with… (More)
- The American review of respiratory disease
Salmeterol is a new beta 2-selective agonist with a long duration of action. We compared the effect of 50 micrograms salmeterol… (More)